 | Up a level |
Arendrup, M C; Friberg, N; Mares, M; Kahlmeter, G; Meletiadis, J; Guinea, J (2020). How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). Clinical microbiology and infection, 26(11), pp. 1464-1472. Elsevier 10.1016/j.cmi.2020.06.007
Schön, T; Matuschek, E; Mohamed, S; Utukuri, M; Heysell, S; Alffenaar, J-W; Shin, S; Martinez, E; Sintchenko, V; Maurer, F P; Keller, P. M.; Kahlmeter, G; Köser, C U (2019). Standards for MIC testing that apply to the majority of bacterial pathogens should also be enforced for Mycobacterium tuberculosis complex. Clinical microbiology and infection, 25(4), pp. 403-405. Elsevier 10.1016/j.cmi.2019.01.019
